Compare UVSP & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UVSP | MRVI |
|---|---|---|
| Founded | 1876 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 1994 | 2020 |
| Metric | UVSP | MRVI |
|---|---|---|
| Price | $41.10 | $6.80 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $45.50 | $8.50 |
| AVG Volume (30 Days) | 194.2K | ★ 2.3M |
| Earning Date | 10-28-2026 | 11-04-2026 |
| Dividend Yield | ★ 2.24% | N/A |
| EPS Growth | ★ 21.32 | 14.29 |
| EPS | ★ 1.78 | N/A |
| Revenue | ★ $328,056,000.00 | $185,743,000.00 |
| Revenue This Year | $8.42 | $14.01 |
| Revenue Next Year | $3.75 | $6.20 |
| P/E Ratio | $23.06 | ★ N/A |
| Revenue Growth | ★ 9.64 | N/A |
| 52 Week Low | $28.04 | $2.55 |
| 52 Week High | $45.46 | $9.42 |
| Indicator | UVSP | MRVI |
|---|---|---|
| Relative Strength Index (RSI) | 46.91 | 43.68 |
| Support Level | $40.49 | $6.49 |
| Resistance Level | $42.10 | $7.60 |
| Average True Range (ATR) | 0.70 | 0.45 |
| MACD | -0.01 | -0.12 |
| Stochastic Oscillator | 60.14 | 17.71 |
Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.